HIGHLIGHTS
- who: Ghulam Shere Raza and colleagues from the Research Unit of Biomedicine, Medical Research Center, Faculty of Medicine, University of Oulu, Oulu, Finland have published the research work: Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis, in the Journal: (JOURNAL) of 22/Oct/2022
- future: The results of multiple studies in preclinical models demonstrate that Rev-Erb is an attractive target for positively influencing dysregulated metabolism inflammation and fibrosis but more specific tools and studies would be needed to increase the information base for the therapeutic potential of these substances interfering . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.